MONTANUCCI, Pia
 Distribuzione geografica
Continente #
NA - Nord America 1.505
EU - Europa 1.169
AS - Asia 363
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
OC - Oceania 1
Totale 3.044
Nazione #
US - Stati Uniti d'America 1.501
IE - Irlanda 285
IT - Italia 213
UA - Ucraina 192
HK - Hong Kong 140
FR - Francia 95
SE - Svezia 93
SG - Singapore 87
CN - Cina 70
DE - Germania 67
FI - Finlandia 55
RU - Federazione Russa 52
VN - Vietnam 42
AT - Austria 34
GB - Regno Unito 33
BE - Belgio 12
CZ - Repubblica Ceca 12
NL - Olanda 10
TR - Turchia 9
KR - Corea 8
CH - Svizzera 7
CA - Canada 4
EU - Europa 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
CO - Colombia 2
GR - Grecia 2
IN - India 2
RO - Romania 2
AU - Australia 1
BR - Brasile 1
DK - Danimarca 1
LB - Libano 1
PH - Filippine 1
PL - Polonia 1
Totale 3.044
Città #
Chandler 323
Dublin 285
San Mateo 142
Hong Kong 140
Jacksonville 113
Boardman 90
Perugia 90
Ann Arbor 68
Medford 63
Princeton 63
Singapore 60
Altamura 56
Wilmington 47
Dong Ket 42
Ashburn 41
Lawrence 41
Andover 40
Beijing 34
Des Moines 30
Redmond 30
Vienna 30
Norwalk 13
Saint Petersburg 13
Woodbridge 11
Brussels 10
Helsinki 10
Los Angeles 9
Assisi 8
Auburn Hills 8
Houston 8
Izmir 8
Shanghai 8
Dallas 7
Philadelphia 7
San Paolo di Civitate 7
Seoul 7
Manfredonia 6
Santa Clara 6
Den Haag 5
Falkenstein 5
Frankfurt Am Main 5
Olomouc 5
Brno 4
Fremont 4
Rome 4
Bratislava 3
Falls Church 3
Moscow 3
Padova 3
Amelia 2
Bogotá 2
Esslingen am Neckar 2
Hanover 2
Lausanne 2
Leawood 2
Naples 2
New York 2
Palermo 2
Piediluco 2
Redwood City 2
Simi Valley 2
Spoleto 2
Tappahannock 2
Amsterdam 1
Ancona 1
Balneário Camboriú 1
Chicago 1
Coral Gables 1
Decatur 1
Easton 1
Florence 1
La Canada Flintridge 1
Lappeenranta 1
Leuven 1
Mcallen 1
Montréal 1
Munich 1
Nürnberg 1
Odunpazari 1
Omaha 1
Ottawa 1
Ponte San Giovanni 1
Prague 1
Saint Louis 1
San Diego 1
Seattle 1
Sesto Fiorentino 1
Slough 1
Stockholm 1
Terni 1
Toledo 1
Toronto 1
Vancouver 1
Zurich 1
Totale 2.077
Nome #
Effects of streptozotocin on beta-cell precursor activatio in human islet derived cell monolayers 98
In vivo HSV-1 T0Ahex gene transfer strategy for Tay-Sachs disease provides a wide distribution of B-Hexosaminidase A and restores the GM2 ganglioside metabolims in the brain animal model 92
PRECURSORI BETA-CELLULARI IN COLTURE DI INSULE PANCREATICHE UMANE SOTTOPOSTE A STRESS IN VITRO 85
MICROENCAPSULATED ISLET ALLOGRAFTS INTO NONIMMUNOSUPPRESSED PATIENTS WITH TYPE 1 DIABETES (TIDM) 80
Microencapsulation of cells and molecular therapy of type 1 diabetes mellitus: The actual state and future perspectives between promise and progress 71
Immunomodulatory effects of human umbelical cord Wharton jelly-derived mesenchymal stem cells (hUCMS) on circulating T-cell subsets in patients with Sjogren's syndrome 69
A comparison of lysosomal enzymes expression levels in peripheral blood of mild- and severe-Alzheimer’s disease and MCI patients: Implications for regenerative medicine approaches 69
Long-term cultured neonatal porcine islet cell monolayers: a potential tissue source for transplant in diabetes. 69
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 67
NMR analysis of non hydrolyzed samples of sodium alginate 66
Alpha and Beta subunits of b-N-acethyl-hexosaminidase are differently regulated during the mammalian brain development: implication for Tay-Sachs disease therapy 66
Effect of all trans retinoic acid on lysosomal alpha-D: -mannosidase activity in Hl-60 cell: correlation with Hl-60 cells differentiation 62
Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts : four cases 62
Neonatal pig liver-derived progenitors for insulin-producing cells: an in vitro study 61
Absence of metabolic cross-correction in Tay-Sachs cells: implication in gene therapy 61
EFFECTS OF POLI-L-LYSINE AND COLLAGEN ON FH-B-TPN CELL DIFFERENTIATION INTO ENDOCRINE CELL PHENOTYPE 58
EFFECTS OF STRPTOZOTOCIN ON IN VITRO LONG TERM CULTURED HUMAN ISLETS CELLS MONOLAYERS 58
Effects Of Streptozotocin On Beta-Cell Precursor Activation In Human Islet Derived Cell Monolayers. 57
Human Umbilical Cord Wharton Jelly-Derived Adult Mesenchymal Stem Cells, in Biohybrid Scaffolds, for Experimental Skin Regeneration 57
Brain-directed gene transfer therapy for Tay-Sachs disease gives rice a wider distribution of the B-Hexosaminidase A 55
Nano-engineered PLLA based biomaterial drives stem cell responses 53
A8. 6 A novel therapeutic approach in systemic rheumatic autoimmune disorders: encapsulated human umbilical cord wharton jelly-derived mesenchymal stem cells 53
Design of a nanocomposite substrate inducing adult stem cell assembly and progression toward an Epiblast-like or Primitive Endoderm-like phenotype via mechanotransduction 53
Reversal of Hyperglycemia by Microencapsulated Human Umbilical Cord Wharton Jelly-Derived Adult Mesenchymal Stem Cells (hUCMS) Graft (TX) in Spontaneously Nonobese Diabetic (NOD) Mice 52
Study of the maternal-foetal interface in women with obesity and gestational diabetes as a potential mirror of foetal programming 52
Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. 52
Human Umbilical Cord Wharton Jelly-derived Adult Mesenchymal Stem Cells (hUCMS) in Microcapsules (CpS): A Novel Biohybrid System for Immunomodulation in T1D 51
Direct brain gene transfer strategy for Tay-Sachs disease 50
Functional Profiles of Human Umbilical Cord-Derived Adult Mesenchymal Stem Cells in Obese/Diabetic Versus Healthy Women 50
Prevention of diabetes in NOD mice by increasing GITR positive Treg cells by low doses of anti-GITR antibody 50
Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model 47
New simple and rapid method for purification of mesenchymal stem cells from the human umbilical cord 47
Microencapsulated G3C hybridoma cell graft delays the onset of spontaneous diabetes in NOD mice by an expansion of Gitr+ Treg cells 47
NMR analysis of sodium alginate 46
Evidence for altered late endosomal-lysosomal compartment in Sandhoff fibroblasts 45
Treatment of diabetes mellitus with microencapsulated fetal human liver (FH-B-TPN) engineered cells 45
Insights in Behavior of Variably Formulated Alginate-Based Microcapsules for Cell Transplantation 45
Surface Hydrophilicity of Poly(l-Lactide) Acid Polymer Film Changes the Human Adult Adipose Stem Cell Architecture 45
In vivo gene transfer strategy for Tay-Sachs disease restores the GM2 ganglioside in the brain of the animal model 45
The functional performance of microencapsulated human pancreatic islet-derived precursor cells. 44
Stem Cells for the Cell and Molecular Therapy of Type 1 Diabetes Mellitus (T1D) between Lights and Shadows 44
Umbilical cord mesenchymal stem cells for the treatment of autoimmune diseases: Beware of cell-to-cell contact 43
A9.18 Potential Therapeutic Application of Human Umbilical Cord wharton Jelly Derived Mesenchymal Stem Cells in Primary Sjogren's Syndrome 43
Remission of hyperglycemia in spontaneously diabetic NOD mice upon transplant of microencapsulated human umbilical cord Wharton jelly-derived mesenchymal stem cells (hUCMS) 43
Molecular Characterization of Postpartum Umbilical Cord Wharton Jelly-derived Human Adult Mesenchymal Stem Cells (hUCMS) in Healthy vs. Obese/Diabetic Mothers 42
ENGINEERED ALGINATE MICROCAPSULES FOR MOLECULAR THERAPY TROUGH BIOLOGIC SECRETING CELLS 42
Clinical grade sodium alginate for microencapsulation of myofibroblasts isolated from wharton jelly for prevention and treatment of autoimmune and inflammatory diseases 41
THERAPEUTIC APPLICATION OF HUMAN UMBILICAL CORD WHARTON JELLY-DERIVED MESENCHYMAL STEM CELLS (HUCMS) IN SYSTEMIC LUPUS ERYTHEMATOSUS: PITFALLS AND PERSPECTIVES 41
Immunomodulatory effects of human umbilical cord wharton jelly-derived mesenchymal stem cells (HUCMS) on circulating T-cell subsets in patients with sjögren’s syndrome 41
Co-microencapsulation of human umbilical cord-derived mesenchymal stem and pancreatic islet-derived insulin producing cells in experimental type 1 diabetes 40
In Vitro Cultured Human Islet Cell Monolayers : Stemness Markers and Insulin Recovery upon Streptozotocin exposure. 39
Directed hexa gene transfer therapy for Tay-Sachs disease provides a wide brain distribution of the B-Hexosaminidase a and restores the GM2 ganglioside metabolism 39
Microencapsulation of Islets for the Treatment of Type 1 Diabetes Mellitus (T1D). 39
Microencapsulated Umbilical Cord Wharton Jelly-Derived Human Mesenchymal Stem Cells for the Cell Therapy of Type 1 Diabetes Mellitus (T1d): Applications and Limits 38
Restoration of t cell substes of patients with type 1 diabetes mellitus by microencapsulated human umbilical cord wharton jelly-derived mesenchymal stem cells: An in vitro study 37
Xenotransplantation of microencapsulated human wharton jelly-derived adult mesenchymal stem cells (HUCMS) into overtly diabetic NOD mice 37
Neonatal Pig Liver – Derived Undifferentiated Cells: A Potential New Source For Insulin Production 35
Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. 34
Utilization of a Commercial 3D Printer for the Construction of a Bio-Hybrid Device Based on Bioink and Adult Human Mesenchymal Cells 32
Microencapsulated Wharton Jelly-derived adult mesenchymal stem cells as a potential new therapeutic tool for patients with COVID-19 disease: an in vitro study 32
Islet transplantation versus stem cells for the cell therapy of type 1 diabetes mellitus 28
Stem cells for pancreatic β-cell replacement in diabetes mellitus 26
In vitro immunomodulatory effects of microencapsulated umbilical cord Wharton jelly-derived mesenchymal stem cells in primary Sjögren's syndrome. 24
ULTRAPURIFIED ALGINATE-BASED MICROCAPSULES FOR IMMUNOPROTECTION OF HUMAN ISLET ALLOGRAFTS IN TYPE 1 DIABETES MELLITUS 23
Emerging of a new CD3+CD31HCD184+ tang cell phenothype in Sjögren's syndrome induced by microencapsulated human umbilical cord matrix-derived multipotent stromal cells 18
Totale 3.236
Categoria #
all - tutte 13.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.411


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020249 0 0 40 6 41 11 30 18 34 35 13 21
2020/2021431 2 29 14 28 146 21 33 4 54 14 38 48
2021/2022516 12 94 41 19 15 4 3 168 4 24 51 81
2022/20231.039 68 185 14 83 79 108 13 43 371 4 47 24
2023/2024413 33 38 23 8 2 4 134 10 25 12 61 63
2024/2025130 11 91 28 0 0 0 0 0 0 0 0 0
Totale 3.236